[Pathophysiology and therapy of L-Dopa-induced dyskinesia].
D000818:Animals; D001479:Basal Ganglia / Q000033:anatomy & histology / Q000502:physiology; D004195:Disease Models, Animal; D015259:Dopamine Agents / Q000009:adverse effects*; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy* / Q000503:physiopathology* / Q000517:prevention & control; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D011941:Receptors, Adrenergic / Q000187:drug effects / Q000502:physiology; D011954:Receptors, Dopamine / Q000187:drug effects / Q000502:physiology; D017470:Receptors, Glutamate / Q000187:drug effects / Q000502:physiology; D011957:Receptors, Opioid / Q000187:drug effects / Q000502:physiology; D018047:Receptors, Purinergic P1 / Q000187:drug effects / Q000502:physiology
D015259:Dopamine Agents; D011941:Receptors, Adrenergic; D011954:Receptors, Dopamine; D017470:Receptors, Glutamate; D011957:Receptors, Opioid; D018047:Receptors, Purinergic P1; D007980:Levodopa
Physiopathologie et modalités thérapeutiques des dyskinésies induites à la L-Dopa.